tiprankstipranks
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
Want to see HK:2269 full AI Analyst Report?

Compare Wuxi Biologics (Cayman) (2269) vs. Competitors

56 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Wuxi Biologics (Cayman)
HK$35.72
HK$137.23B
24.33
37.23%
11 Buy
1 Hold
0 Sell
Strong Buy
Genscript Biotech
HK$13.76
HK$28.49B
-6.49
25.62%
5 Buy
0 Hold
0 Sell
Strong Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$51.05B
22.45
36.62%
7 Buy
0 Hold
0 Sell
Strong Buy
Frontage Holdings Corp.
HK$1.03
HK$1.94B
38.94
-15.18%
Viva Biotech Holdings
HK$1.76
HK$3.07B
17.96
-17.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$20.67B
25.33
299.68%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2269
Wuxi Biologics (Cayman)
33.14
8.44
34.17%
HK:1548
Genscript Biotech
13.09
2.15
19.65%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
18.28
4.86
36.19%
HK:1521
Frontage Holdings Corp.
0.95
-0.18
-15.93%
HK:1873
Viva Biotech Holdings
1.45
-0.28
-16.18%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
50.60
36.32
254.34%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts